New York Assembly Bill A01667

New York 2025-2026 Regular Session

• Introduced: 1/10/25
• Refer: 1/10/25
• Refer: 1/7/26

Caption

Relates to establishing an office of antibiotic-resistance control; establishes the antibiotics education fund; includes methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections in the definition of airborne infectious disease.

Summary

Bill A01667 aims to address the growing public health threat posed by antibiotic-resistant infections by establishing an Office of Antibiotic-Resistance Control within the New York State Department of Health. This office will coordinate state efforts to combat antibiotic resistance through monitoring, education, and the implementation of best practices in both healthcare and agricultural settings. The bill also creates an Antibiotics Education Fund to support educational programs aimed at promoting responsible antibiotic use. Additionally, it expands the definition of airborne infectious diseases to include methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections, thereby enhancing public health protections against these threats. The legislation outlines specific goals, such as reducing healthcare-associated antibiotic-resistant infections by 20% and community-acquired infections by 10% by 2027, as well as a 50% reduction in the use of medically important antibiotics in food animal production within five years. The bill emphasizes a 'One Health' approach, recognizing the interconnectedness of human and animal health in combating antibiotic resistance. It also mandates reporting requirements for antibiotic use in food-producing animals and establishes penalties for violations of the new regulations. By establishing a structured framework for antibiotic stewardship and control, this bill seeks to mitigate the risks associated with antibiotic misuse and overuse, which are contributing to the rise of 'superbugs'. The bill's provisions aim to enhance collaboration among various stakeholders, including healthcare providers, veterinarians, and agricultural producers, to ensure a comprehensive response to antibiotic resistance. Overall, the bill reflects a proactive approach to a significant public health crisis, aligning with national and international efforts to combat antibiotic resistance. It has garnered support from various health organizations, but may face challenges related to its implementation and the potential impact on agricultural practices.

Impact

If enacted, Bill A01667 will significantly alter the landscape of antibiotic usage in New York State by instituting stricter regulations on the prescription and administration of antibiotics in both healthcare and agricultural contexts. The establishment of the Office of Antibiotic-Resistance Control will centralize efforts to monitor and educate on antibiotic use, potentially leading to improved public health outcomes. The inclusion of antibiotic-resistant infections in the definition of airborne diseases may also lead to heightened awareness and response measures in healthcare settings. The bill's focus on data collection and reporting will provide valuable insights into antibiotic use patterns and resistance trends, informing future policy decisions.

Sentiment

The sentiment surrounding Bill A01667 appears to be generally supportive among public health advocates and medical professionals, who recognize the urgency of addressing antibiotic resistance. However, there may be concerns from agricultural stakeholders regarding the implications of stricter antibiotic regulations on farming practices. The lack of recorded votes or committee discussions at this stage suggests that the bill is still in the early phases of consideration, and further debate may clarify positions among various interest groups.

Contention

Notable points of contention may arise from stakeholders in the agricultural sector, particularly regarding the limitations on antibiotic use for disease prevention and growth promotion in livestock. Producers may argue that such restrictions could impact their operations and animal health management practices. Additionally, there may be discussions around the financial implications of implementing the proposed educational programs and the potential administrative burden on healthcare providers and veterinarians tasked with compliance.